missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ NAPSA Recombinant Rabbit Monoclonal Antibody (PD01-30)

Description
Positive control: Human lung carcinoma tissue, human kidney tissue. Predicted band size: 45 kDa Subcellular Location: Secreted.
Napsin 1 is an aspartic protease that is generally expressed in the lung, but also present in kidney and in metastatic carcinomas throughout the body. Napsin 1 processes surfactant protein B in healthy pulmonary and renal tissues, but is abnormally regulated when carcinogenesis occurs. Thus, many researchers have found napsin evaluation to be useful in identifying several cancers, and differentiating primary tumors from metastases. When combined with thyroid transcription factor analysis, napsin can be used as a specific biomarker for differentiation of carcinoma types. Napsin has also been associated with pulmonary alveolar proteinosis as well as in protein catabolism in renal tubules.
Specifications
Specifications
| Antigen | NAPSA |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Recombinant Monoclonal |
| Clone | PD01-30 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.1% BSA, 40% glycerol and 0.05% sodium azide; pH 7.4 |
| Gene | NAPSA |
| Gene Accession No. | O96009 |
| Gene Alias | asp 4; ASP4; Aspartyl protease 4; KAP; Kdap; KDAP-1; kidney-derived aspartic protease-like protein; Nap; NAP1; NAPA; Napsa; napsin A aspartic peptidase; napsin-1; Napsin-A; pronapsin; pronapsin A; SNAPA; TA01/TA02 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?